Comparison of four approaches in eliciting health state utilities with SF-6Dv2 [0.03%]
基于SF-6Dv2健康状态效用值的四种评估方法比较研究
Hosein Ameri,Thomas G Poder
Hosein Ameri
Objective: To empirically compare four preference elicitation approaches, the discrete choice experiment with time (DCETTO), the Best-Worst Scaling with time (BWSTTO), DCETTO with BWSTTO (DCEBWS), and the Standard Gamble ...
Comparing EQ-5D-5L, PROPr, SF-6D and TTO utilities in patients with chronic skin diseases [0.03%]
比较慢性皮肤病患者中EQ-5D-5L、PROPr、SF-6D和TTO效用价值
Ákos Szabó,Valentin Brodszky,Fanni Rencz
Ákos Szabó
Objectives: We aim to compare the measurement properties of three indirect (EQ-5D-5L, PROPr, SF-6D) and one direct (time trade-off, TTO) utility assessment methods in patients with chronic skin diseases. ...
Assessing a decade of leukaemia-related premature mortality costs: impact on productivity loss in Spain [0.03%]
西班牙白血病相关过早死亡成本的十年评估：对生产力损失的影响
Josep Darbà,Meritxell Ascanio,Ainoa Agüera
Josep Darbà
Introduction: Cancer mortality is one of the dominant causes of productivity loss; and within all cancer sites, blood cancer is the fourth most common cause of death in Spain. Thus, its impacts in work productivity are a ...
Strategic behavior and entry deterrence by branded drug firms: the case of authorized generic drugs [0.03%]
名牌药企的战略行为与以授权生产通用名药形式的阻止竞争行为：一个案例分析
Lu Yao,Mengde Liu
Lu Yao
Pharmaceutical firms that market brand-name drugs lose substantial market share to generic manufacturers after patent expiration. As a response to the threat of generic competition, branded manufacturers pursue defensive strategies. One suc...
Does implementing opt-out solve the organ shortage problem? Evidence from a synthetic control approach [0.03%]
选择退出式器官捐赠登记会缓解供体短缺问题吗？来自合成控制法的证据
Selina Schulze Spuentrup
Selina Schulze Spuentrup
In light of the persistent shortage of organ donations needed to save precious human lives, several countries have modified their organ donation laws by introducing an opt-out system, making every deceased a potential organ donor unless the...
An assessment of the implications of distribution remuneration and taxation policies on the final prices of prescription medicines: evidence from 35 countries [0.03%]
分配报酬和税收政策对35个国家处方药最终价格影响的评估：来自35个国家的证据
Giovanny Leon,Christophe Carbonel,Aparajit Rampuria et al.
Giovanny Leon et al.
This paper analyses the structure of and variability in taxation and prescription drug distribution policies and quantifies the impact of such policies on the cost of prescription drugs to health systems in 35 countries. Taxes on prescripti...
Should Scotland provide genome-wide sequencing for the diagnosis of rare developmental disorders? A cost-effectiveness analysis [0.03%]
苏格兰应提供全基因组测序来诊断罕见发育障碍吗？一项成本效益分析
Michael Abbott,Mandy Ryan,Rodolfo Hernández et al.
Michael Abbott et al.
Aims: This study aims to evaluate the cost effectiveness of genetic and genomic testing strategies for the diagnosis of rare developmental disorders in NHS Scotland. ...
Abeer Al Rabayah,Bram Roudijk,Fredrick Dermawan Purba et al.
Abeer Al Rabayah et al.
Background: In Jordan, no national value set is available for any preference-accompanied health utility measure. Objective: This study ...
The added value of the cognition, dining, gastrointestinal problems, sleep and tiredness bolt-on dimensions to the EQ-5D-5L in patients with coeliac disease [0.03%]
关于celiac病患者认知、饮食、胃肠问题、睡眠和疲劳维度对EQ-5D-5L增益价值的系统评价和 meta 分析
M Mercédesz Angyal,Mathieu F Janssen,Péter L Lakatos et al.
M Mercédesz Angyal et al.
Objectives: Multiple studies suggest that the EQ-5D may overestimate health-related quality of life (HRQoL) in patients with coeliac disease (CD). We aimed to develop and psychometrically test potentially relevant bolt-on...
Trends in NICE technology appraisals of non-small cell lung cancer drugs over the last decade [0.03%]
英国NICE过去十年肺癌药物评估的变迁趋势分析
Lotte Westerink,Sharon Wolters,Guiling Zhou et al.
Lotte Westerink et al.
Objectives: The aim of this study is to analyse the trends in technology appraisals for non-small cell lung cancer (NSCLC) treatments performed by the National Institute for Health and Care Excellence (NICE) over the last...